Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNP
4501
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $69K | ﹤0.01% |
11,500
-11,100
| -49% | -$81.7K |
|
4502
Apogee Enterprises
APOG
$887M
| $68K | ﹤0.01% |
1,585
+272
| +21% | +$10.8K |
|
|
CIM
4503
CALL
Chimera Investment
CIM
$980M
| $68K | ﹤0.01% |
1,733
+933
| +117% | +$36.3K |
|
4504
CALL
IDT Corp
IDT
$1.61B
| $68K | ﹤0.01% |
6,372
+708
| +13% | +$6.4K |
|
4505
PUT
Lands' End
LE
$402M
| $68K | ﹤0.01% |
2,700
-20,730
| -88% | -$486K |
|
4506
PUT
Invesco DB US Dollar Index Bearish Fund
UDN
$109M
| $68K | ﹤0.01% |
3,100
+2,100
| +210% | +$45.6K |
|
|
CBPX
4507
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $68K | ﹤0.01% |
3,779
-14,121
| -79% | -$229K |
|
|
SQI
4508
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $68K | ﹤0.01% |
5,204
+3,418
| +191% | +$43.1K |
|
|
CRC
4509
CALL
DELISTED
California Resources Corporation
CRC
| $68K | ﹤0.01% |
6,761
+2,149
| +47% | +$25.4K |
|
4510
FerroAtlántica
GSM
$865M
| $67K | ﹤0.01% |
8,347
-251,176
| -97% | -$2.17M |
|
4511
PUT
Amplify Cybersecurity ETF
HACK
$3.01B
| $67K | ﹤0.01% |
2,900
-3,200
| -52% | -$72.1K |
|
|
MWW
4512
PUT
DELISTED
Monster Worldwide Inc
MWW
| $67K | ﹤0.01% |
22,400
+22,200
| +11,100% | +$86.3K |
|
|
TIVO
4513
CALL
DELISTED
TIVO INC
TIVO
| $67K | ﹤0.01% |
7,400
+2,100
| +40% | +$16.9K |
|
4514
Ennis
EBF
$558M
| $66K | ﹤0.01% |
+3,483
| New | +$67.9K |
|
|
ABB
4515
DELISTED
ABB Ltd
ABB
| $66K | ﹤0.01% |
3,489
+531
| +18% | +$9.38K |
|
|
IVC
4516
CALL
DELISTED
Invacare Corporation
IVC
| $66K | ﹤0.01% |
+5,100
| New | +$72.3K |
|
|
XLRN
4517
DELISTED
Acceleron Pharma
XLRN
| $66K | ﹤0.01% |
2,514
+2,024
| +413% | +$58.9K |
|
|
NXTM
4518
DELISTED
NxStage Medical Inc.
NXTM
| $66K | ﹤0.01% |
4,721
-9,079
| -66% | -$152K |
|
|
AIQ
4519
DELISTED
Alliance Healthcare Services
AIQ
| $66K | ﹤0.01% |
9,321
-2,679
| -22% | -$19.5K |
|
4520
Agree Realty
ADC
$9.22B
| $65K | ﹤0.01% |
1,708
-1,931
| -53% | -$70.2K |
|
4521
CALL
Commault Systems
CVLT
$5.78B
| $65K | ﹤0.01% |
1,500
+1,300
| +650% | +$48.1K |
|
4522
PUT
Dolby
DLB
$5.82B
| $65K | ﹤0.01% |
+1,500
| New | +$55.7K |
|
4523
Enanta Pharmaceuticals
ENTA
$402M
| $65K | ﹤0.01% |
2,244
+1,862
| +487% | +$51.8K |
|
4524
German American Bancorp
GABC
$1.87B
| $65K | ﹤0.01% |
+3,039
| New | +$64.1K |
|
4525
Hanmi Financial
HAFC
$939M
| $65K | ﹤0.01% |
2,971
+2,933
| +7,718% | +$62.7K |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.